Publikace
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | 1. lékařská fakulta, 2. lékařská fakulta
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice2017 | 2. lékařská fakulta
- Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death2017 | 2. lékařská fakulta
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | 2. lékařská fakulta
- High hydrostatic pressure induces immunogenic cell death in human tumor cells2014 | 2. lékařská fakulta
- Consensus guidelines for the detection of immunogenic cell death2014 | 2. lékařská fakulta
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | 2. lékařská fakulta
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Imunogenní buněčná smrt a její aplikace v imunoterapeutických protokolechPublikace bez příslušnosti k fakultě
- Type I interferon and cancer2024 | 2. lékařská fakulta
Loading network view...